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Authors’ response
We would like to thank the Author [1] of the 
letter for kind and valuable comments concerning 
our study [2]. We are glad to supplement some 
information here.
Increased mean platelet volume (MPV) has 
been noted in subjects with cardiovascular risk 
factors, such as smoking, diabetes, obesity, hy-
pertension, and hyperlipidemia [3]. In subjects 
with established cardiovascular disease, elevated 
MPV may be a marker for adverse cardiovascular 
events. Elevated MPV is associated with acute 
myocardial infarction, mortality following my-
ocardial infarction, and restenosis following coro-
nary angioplasty. These data suggest that MPV is 
a potentially useful prognostic biomarker in patients 
with cardiovascular disease. Whether the relation-
ship is causal, and whether MPV should influence 
practice or guide therapy, remains unknown. Most 
conditions, including traditional risk factors (e.g. 
hypertension, atherogenic lipoproteins, obesity, 
and hyperglycemia) and many inflammatory con-
ditions (e.g. infection and inflammatory diseases) 
can influence MPV.
Since our patients and control subjects are 
young and the study population is relatively small, 
we did not need to give the exact values in the text 
comparing the MPV values according to cardio-
vascular risk factors such as lipids, blood glucose 
levels and blood pressure levels between patients 
and control groups [1]. With regard to body mass 
index and smoking status, however, the patient 
subgroups and control subjects were identical. In 
our study, all the patients with infective endocar-
ditis had valvular heart disease. It is possible that 
basal valvular involvement by itself can contribute 
to the elevation of MPV values. Studies with large 
sample size and better control of the confounding 
factors (namely cardiovascular risk factors) affec-
ting MPV are needed to clarify the relationship 
between infective endocarditis and MPV.
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